Home page Home page
AstraZeneca

Torisel
temsirolimus

Package leaflet: Information for the patient


Torisel 30 mg concentrate and solvent for solution for infusion

temsirolimus


Read all of this leaflet carefully before you are given this medicine because it contains important information for you

for injection to ensure adequate mixing.

The admixture should be mixed by inversion of the bag or bottle, avoiding excessive shaking, as this may cause foaming.


The final diluted solution in the bag or bottle should be inspected visually for particulate matter and discolouration prior to administration. The admixture of Torisel in sodium chloride 9 mg/ml (0.9%) solution for injection should be protected from excessive room light and sunlight.


For mantle cell lymphoma, multiple vials will be required for each dose over 25 mg.


Administration



Disposal


Any unused medicinal product or waste material should be disposed of in accordance with local requirements.